Edward Yu1,2, Frank B Hu3,4,5. 1. Department of Nutrition, Harvard T.H. Chan School of Public Health, 655 Huntington Avenue, Build II Floor 3, Boston, MA, 02115, USA. 2. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, USA. 3. Department of Nutrition, Harvard T.H. Chan School of Public Health, 655 Huntington Avenue, Build II Floor 3, Boston, MA, 02115, USA. frank.hu@channing.harvard.edu. 4. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, USA. frank.hu@channing.harvard.edu. 5. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA. frank.hu@channing.harvard.edu.
Abstract
PURPOSE OF REVIEW: To examine recent literature on dairy products, dairy fatty acids, and cardiometabolic disease. Primary questions of interest include what unique challenges researchers face when investigating dairy products/biomarkers, whether one should consume dairy to reduce disease risk, whether dairy fatty acids may be beneficial for health, and whether one should prefer low- or high-fat dairy products. RECENT FINDINGS: Dairy composes about 10% of the calories in a typical American diet, about half of that coming from fluid milk, half coming from cheese, and small amounts from yogurt. Most meta-analyses report no or weak inverse association between dairy intake with cardiovascular disease and related intermediate outcomes. There is some suggestion that dairy consumption was inversely associated with stroke incidence and yogurt consumption was associated with lower risk of type 2 diabetes. Odd chain fatty acids (OCFAs) found primarily in dairy (15:0 and 17:0) appear to be inversely associated with cardiometabolic risk, but causation is uncertain. Substitution analyses based on prospective cohorts suggested that replacing dairy fat with vegetable fat or polyunsaturated fat was associated with significantly lower risk of cardiovascular disease. Current evidence suggests null or weak inverse association between consumption of dairy products and risk of cardiovascular disease. However, replacing dairy fat with polyunsaturated fat, especially from plant-based foods, may confer health benefits. More research is needed to examine health effects of different types of dairy products in diverse populations.
PURPOSE OF REVIEW: To examine recent literature on dairy products, dairy fatty acids, and cardiometabolic disease. Primary questions of interest include what unique challenges researchers face when investigating dairy products/biomarkers, whether one should consume dairy to reduce disease risk, whether dairy fatty acids may be beneficial for health, and whether one should prefer low- or high-fatdairy products. RECENT FINDINGS:Dairy composes about 10% of the calories in a typical American diet, about half of that coming from fluid milk, half coming from cheese, and small amounts from yogurt. Most meta-analyses report no or weak inverse association between dairy intake with cardiovascular disease and related intermediate outcomes. There is some suggestion that dairy consumption was inversely associated with stroke incidence and yogurt consumption was associated with lower risk of type 2 diabetes. Odd chain fatty acids (OCFAs) found primarily in dairy (15:0 and 17:0) appear to be inversely associated with cardiometabolic risk, but causation is uncertain. Substitution analyses based on prospective cohorts suggested that replacing dairyfat with vegetable fat or polyunsaturated fat was associated with significantly lower risk of cardiovascular disease. Current evidence suggests null or weak inverse association between consumption of dairy products and risk of cardiovascular disease. However, replacing dairyfat with polyunsaturated fat, especially from plant-based foods, may confer health benefits. More research is needed to examine health effects of different types of dairy products in diverse populations.
Authors: F B Hu; E Rimm; S A Smith-Warner; D Feskanich; M J Stampfer; A Ascherio; L Sampson; W C Willett Journal: Am J Clin Nutr Date: 1999-02 Impact factor: 7.045
Authors: Lieke Gijsbers; Eric L Ding; Vasanti S Malik; Janette de Goede; Johanna M Geleijnse; Sabita S Soedamah-Muthu Journal: Am J Clin Nutr Date: 2016-02-24 Impact factor: 7.045
Authors: Benjamin J Jenkins; Kevin Seyssel; Sally Chiu; Pin-Ho Pan; Shih-Yi Lin; Elizabeth Stanley; Zsuzsanna Ament; James A West; Keith Summerhill; Julian L Griffin; Walter Vetter; Kaija J Autio; Kalervo Hiltunen; Stéphane Hazebrouck; Renata Stepankova; Chun-Jung Chen; Maud Alligier; Martine Laville; Mary Moore; Guillaume Kraft; Alan Cherrington; Sarah King; Ronald M Krauss; Evelyn de Schryver; Paul P Van Veldhoven; Martin Ronis; Albert Koulman Journal: Sci Rep Date: 2017-03-23 Impact factor: 4.379
Authors: Kristin M Hirahatake; Richard S Bruno; Bradley W Bolling; Christopher Blesso; Lacy M Alexander; Sean H Adams Journal: Adv Nutr Date: 2020-03-01 Impact factor: 8.701
Authors: Jean-Philippe Drouin-Chartier; Yanping Li; Andres Victor Ardisson Korat; Ming Ding; Benoît Lamarche; JoAnn E Manson; Eric B Rimm; Walter C Willett; Frank B Hu Journal: Am J Clin Nutr Date: 2019-11-01 Impact factor: 7.045
Authors: Kristin M Hirahatake; Arne Astrup; James O Hill; Joanne L Slavin; David B Allison; Kevin C Maki Journal: Adv Nutr Date: 2020-05-01 Impact factor: 8.701
Authors: Jean-Philippe Drouin-Chartier; Pablo Hernández-Alonso; Marta Guasch-Ferré; Miguel Ruiz-Canela; Jun Li; Clemens Wittenbecher; Cristina Razquin; Estefanía Toledo; Courtney Dennis; Dolores Corella; Ramon Estruch; Montserrat Fitó; A Heather Eliassen; Deirdre K Tobias; Alberto Ascherio; Lorelei A Mucci; Kathryn M Rexrode; Elizabeth W Karlson; Karen H Costenbader; Charles S Fuchs; Liming Liang; Clary B Clish; Miguel A Martínez-González; Jordi Salas-Salvadó; Frank B Hu Journal: Am J Clin Nutr Date: 2021-07-01 Impact factor: 7.045